Tumor-Induced Osteomalacia
Also known as: Tumor Induced Oncogenic Osteomalacia / Oncogenic Osteomalacia / Tumor-induced Osteomalacia (TIO) / Tumor Induced Osteomalacia (TIO) / Osteomalacia due to neoplastic disease (disorder) / Hypophosphataemic osteomalacia / Hypophosphatemic osteomalacia
Drug | Drug Name | Drug Description |
---|---|---|
DB14012 | Burosumab | A fibroblast growth factor 23 blocking antibody used to treat X-linked hypophosphatemia. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB14012 | Burosumab | Fibroblast growth factor 23 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB13925 | Dotatate gallium Ga-68 | 0 | Unknown Status | 1 |
DB13925 | Dotatate gallium Ga-68 | 1 | Unknown Status | 1 |
DB16323 | Satoreotide tetraxetan | 1 | Unknown Status | 1 |
DB14012 | Burosumab | 2 | Completed | 1 |
DB11886 | Infigratinib | 2 | Terminated | 1 |
DB14012 | Burosumab | 4 | Active Not Recruiting | 1 |
DB14012 | Burosumab | Not Available | Available | 1 |